Ignyta
San Diego, US · Founded 2011 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
VH
Valerie Harding, Ph.D.Senior Vice President, Chemistry, Manufacturing and Controls
BP
Bernard ParkerChief Commercial Officer
ZH
Zachary HornbyChief Operating Officer
IP
Igor P. Bilinsky, Ph.D.Executive Officer
MO
Matt Onaitis, J.D.Secretary and General Counsel
RW
Robert Wild, Ph.D.Chief Scientific Officer and SVP, Research
JF
James Freddo, M.D.Director
JE
Jonathan E. Lim, M.D.President and Chief Executive Officer
JC
Jacob Chacko, M.D.Chief Financial Officer
AC
Alex CasdinDirector
JB
James Bristol, Ph.D.Director
HD
Heiner Dreismann, Ph.D.Director
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$30MraisedNov 2015 · 1 investors · BiotechnologyRule 506(b)
▶$30MraisedNov 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Valerie Harding, Ph.D.Executive Officer
- Bernard ParkerExecutive Officer
- Zachary HornbyExecutive Officer
- Igor P. Bilinsky, Ph.D.Executive Officer
- Matt Onaitis, J.D.Executive Officer
- Robert Wild, Ph.D.Executive Officer
- James Freddo, M.D.Director
- Jonathan E. Lim, M.D.Executive Officer, Director
- Jacob Chacko, M.D.Executive Officer
- Alex CasdinDirector
- James Bristol, Ph.D.Director
- Heiner Dreismann, Ph.D.Director
- Pratik S. Multani, M.D.Executive Officer
- Offering amount
- $39M
- Amount sold
- $30M
- First sale
- Nov 2015
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.